Streetbeat News

Equity Actions

NBIX

VYGR

Voyager Therapeutics and Neurocrine Biosciences have selected a lead development candidate for Friedreich's Ataxia, planning to advance into human trials in 2025. The candidate utilizes a frataxin gene replacement payload and a novel capsid from Voyager's TRACER platform.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:13 pm

TWLO

Legion Partners, holding 601,050 shares of Twilio, has sent a letter to Twilio's board urging the company to sell its Segment business and significantly expand its stock buyback program.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:09 pm

FIS

FIS has announced an increase of $500 million to its share repurchase goal, signaling a strong commitment to returning value to shareholders and confidence in the company's financial health.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:06 pm

BCRX

BioCryst Pharmaceuticals forecasts its fiscal year 2024 net revenue for Orladeyo to be between $380M-$400M. The company anticipates operating profit in 2024, with expectations of approaching positive EPS and achieving positive cash flow in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:03 pm

SWN

In the last three months, 8 analysts have provided diverse ratings on Southwestern Energy (NYSE:SWN), with a shift towards a more neutral stance in the last 30 days. The average 12-month price target is $7.39, slightly down by 0.4%. The company faces challenges in market capitalization, revenue growth, net margin, ROE, ROA, and debt management, indicating potential difficulties in achieving strong profitability and efficient asset utilization.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 12:02 pm

HLMN

Hillman Solns (NASDAQ:HLMN) has received mixed ratings from analysts, with 4 recent ratings ranging from bullish to indifferent. The average 12-month price target is $11.25, up from $11.00, with high and low estimates of $14.00 and $9.00 respectively. Analysts from Barclays, Canaccord Genuity, and Stifel have adjusted their ratings and price targets, reflecting a nuanced view of the company's prospects. Despite a dominant market position, Hillman Solns faces challenges such as a decline in revenue growth, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 12:00 pm

PLTK

Playtika announces plans to allocate $600M-$1.2B for mergers and acquisitions over the next three years, initiate a quarterly dividend of $0.10 per share, and explore additional shareholder return enhancements such as a share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 11:40 am

TPG

TPG Inc. announced that certain stockholders intend to offer 15.5M shares of TPG's Class A common stock in a secondary stock offering. The offering is based on a shelf registration statement filed with the SEC. All proceeds will go to the Selling Stockholders, with TPG not selling any shares or receiving any proceeds from this offering.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 11:30 am

IBM

IBM has made updates to its management system and reporting segments, including the divestiture of the Weather Company and the relocation of Security Services to its Consulting segment. These updates are stated not to impact IBM's consolidated results.

Portfolio Pulse from Charles Gross

February 26, 2024 | 11:18 am

DPZ

Domino's Pizza's Board of Directors authorized an additional $1 billion stock buyback program, increasing the total authorization for future share repurchases to $1.14 billion. This follows the repurchase and retirement of 167,572 shares for $58.2 million during Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 11:14 am